Tag: Progression-Free Survival

A meta-analysis of ten trials in 2162 patients found that first-line EGFR-TKI plus chemotherapy improved progression-free and overall survival in ...

A study in Breast Cancer Research found that metabolic response measured by FDG-PET/CT is associated with longer progression-free survival in ...

A multicenter retrospective study of 54 patients found that lorlatinib significantly extended progression-free survival compared to earlier-generation inhibitors in ALK ...

A multicenter real-world study has reported that combining trastuzumab deruxtecan with osimertinib may offer clinical benefit for patients with HER2-overexpressing ...

A retrospective registry study indicates that daratumumab-based therapy in the first two treatment lines is associated with improved survival and ...

A retrospective study of 248 breast cancer patients found that HER2-low, HER2-zero, and HER2-overexpressing tumors show distinct glucose metabolism patterns ...

A retrospective study reveals that the preoperative low-density to non-low-density lipoprotein cholesterol ratio correlates with clear cell renal cell carcinoma ...

Neuropathological analyses demonstrate that elevated calbindin D28K expression marks approximately thirty percent of primary meningiomas and independently associates with shortened ...

A retrospective study found that combining neuronavigation with intraoperative MRI and neuromonitoring raised complete resection rates and extended survival in ...

In a retrospective multicenter study of 50 patients with epithelioid mesothelioma, complete BAP1 loss occurred predominantly in pleural tumors and ...